Eye Pressure Test Results: What They Mean for Glaucoma Risk

An eye pressure reading is one of those numbers that can sound more definite than it really is. A patient hears “your pressure is 24” or “your pressure is normal,” and it is natural to want a simple answer: Do I have glaucoma, or not?

The truth is more nuanced. Eye pressure is important, sometimes very important, but it is not the whole story. I have seen people with pressures in the low twenties who never develop glaucomatous damage, and I have seen patients with pressures in the mid teens who already have clear optic nerve and visual field changes. The number matters, but it has to be interpreted alongside the optic nerve, corneal thickness, age, family history, retinal imaging glaucoma findings, and visual field testing results.

That is why an eye pressure test is best understood as a starting point, not a verdict. It is one measurement in a risk profile. When read properly, it helps identify who needs observation, who needs further testing, and who needs treatment to protect vision over the long term.

What an eye pressure test measures

The eye maintains its shape partly because of fluid pressure inside it. This pressure is called intraocular pressure, often abbreviated as IOP. The fluid involved is not the tears on the surface of the eye. It is aqueous humor, a clear fluid produced inside the eye, circulating through the front chamber, and draining through specialized tissue near the angle where the cornea and iris meet.

When production and drainage stay in balance, pressure remains in a typical range. When drainage is reduced or resistance increases, pressure may rise. Over time, elevated pressure can stress the optic nerve, the cable-like structure that carries visual information from the eye to the brain. Glaucoma develops when optic nerve tissue is damaged in a characteristic pattern, often with corresponding loss of peripheral vision.

An eye pressure test does not directly measure optic nerve health. It measures force. The common unit is millimeters of mercury, written as mmHg. Many clinics refer to a “normal” eye pressure range of about 10 to 21 mmHg. That range is useful for orientation, but it is not a safety guarantee. A pressure of 19 may be too high for one optic nerve and perfectly tolerated by another. A pressure of 23 may prompt close follow-up rather than immediate treatment if the optic nerve looks healthy and other risk factors are low.

In practice, clinicians do not ask only, “Is this pressure normal?” They ask, “Is this pressure appropriate for this eye?”

How eye pressure is measured

Several devices can measure intraocular pressure, and each has strengths and limitations. The method used can affect the reading by a few points, which is enough to matter when someone sits near a treatment threshold.

Goldmann applanation tonometry is still widely considered the clinical reference standard. It is the blue-light test performed at the slit lamp after numbing drops and fluorescein dye are placed on the eye. The instrument gently touches the cornea and estimates pressure based on how much force is needed to flatten a small area. When performed carefully, it gives reliable results, but it depends on proper technique and corneal characteristics.

Many patients first encounter non-contact tonometry, the “air puff” test. It is quick and does not require numbing drops. It is useful for screening, especially in busy settings, but it may be less precise in some situations. Readings can run higher if a patient squeezes their eyelids, pulls back from the puff, or holds their breath.

Handheld devices, such as rebound tonometers or portable applanation units, are common in pediatric care, emergency settings, nursing facilities, and situations where a patient cannot sit comfortably at a slit lamp. These tools are extremely helpful, though clinicians still interpret results in context.

The important point for patients is that a single number is not always final. If a pressure reading seems unexpectedly high, many eye care professionals repeat it, check technique, compare both eyes, and consider whether corneal thickness may be influencing the result.

What counts as a high eye pressure result?

A pressure above 21 mmHg is often called ocular hypertension if the optic nerve and visual field remain normal. It does not automatically mean glaucoma. It means the pressure is higher than the statistical average range and deserves a closer look.

The level of concern increases as pressure rises, especially when other risk factors are present. A reading of 22 or 23 mmHg in one eye with a thick cornea, healthy optic nerve, no family history, and normal imaging may lead to monitoring. A reading of 28 or 30 mmHg, particularly if repeated and paired with suspicious optic nerve appearance, usually triggers a more urgent conversation about treatment. Pressures in the 40s or higher can be seen in acute or severe situations and may require prompt intervention, depending on symptoms and the cause.

Clinicians also pay attention to asymmetry. If one eye consistently measures 16 and the other 24, that difference may be more meaningful than either number alone. Glaucoma often affects the eyes unevenly, particularly early on.

Time of day matters too. Eye pressure fluctuates. Some people run higher in the morning; others peak later. A patient may show 17 at a mid-afternoon visit yet reach the low twenties at another time. For someone with progressive optic nerve changes despite apparently acceptable office readings, the clinician may suspect pressure peaks outside the exam window.

Why “normal pressure” does not always mean low risk

Normal-tension glaucoma is one of the reasons eye pressure results require caution. In this form of glaucoma, optic nerve damage occurs even though measured pressure usually stays within the traditional normal range. These patients may have optic nerves more vulnerable to pressure, reduced blood flow regulation, vascular risk factors, or other contributing features that are not fully captured by a tonometry reading.

This can be frustrating for patients. They may say, “But my pressure has always been normal.” That may be true, and the glaucoma diagnosis may still be valid if optic nerve thinning, retinal nerve fiber layer loss, and repeatable visual field defects are present.

Normal-tension glaucoma also changes the treatment conversation. The goal is still usually to lower eye pressure, even when the starting pressure is not high. Large clinical studies have shown that reducing pressure can slow glaucoma progression in many patients, including those with normal-tension disease. The target may be a percentage reduction from baseline rather than a specific universal number.

For example, if a patient’s untreated pressure tends to be 16 mmHg but visual field testing shows progression, a clinician may aim for 12 or lower. Another patient with stable nerves and no progression may not need the same aggressive target. The number is individualized.

The role of corneal thickness

Corneal thickness can make an eye pressure test read higher or lower than the true internal pressure. A thicker-than-average cornea may resist flattening, causing applanation readings to overestimate pressure. A thinner cornea may flatten more easily, causing readings to underestimate pressure.

Central corneal thickness is measured with pachymetry, a quick test usually done with an ultrasound probe or optical device. Average central corneal thickness is often around the mid-500 micrometer range, though normal variation is broad.

Thin corneas matter for two reasons. First, they can hide higher true pressure. Second, thin corneal thickness has been associated with increased glaucoma risk in ocular hypertension studies. This does not mean every person with thin corneas will develop glaucoma, but it shifts the risk calculation.

Consider two patients who both measure 22 mmHg. One has corneas measuring 610 micrometers and large, healthy optic nerves. The other has corneas measuring 490 micrometers and subtle nerve fiber layer thinning on imaging. Those two patients do not have the same risk, even though their pressure number matches.

Eye pressure and the optic nerve: the relationship that matters most

Glaucoma is ultimately a disease of the optic nerve, not just a disease of pressure. During a dilated eye exam, the clinician examines the optic disc, where nerve fibers exit the eye. A healthy optic nerve has a rim of neural tissue surrounding a central cup. In glaucoma, the rim can thin, the cup can enlarge, and the nerve fiber layer can develop localized defects.

Some optic nerves are naturally large and have large cups without glaucoma. Others are small and crowded. This is where experience matters. A cup-to-disc ratio written in a chart can be useful, but it is not enough by itself. The shape of the rim, symmetry between eyes, disc hemorrhages, nerve fiber layer appearance, and progression over time all carry weight.

A small hemorrhage at the edge of the optic nerve, called a disc hemorrhage, can be an important warning sign. It may appear even when pressure seems controlled. In a busy clinic, these hemorrhages can be easy to miss unless the nerve is examined carefully or documented with photography.

The question is not merely whether the optic nerve looks suspicious today. The more powerful question is whether it has changed. Glaucoma monitoring depends heavily on detecting change before the patient notices symptoms.

Retinal imaging glaucoma tests: what they add

Retinal imaging has changed glaucoma care substantially. Optical coherence tomography, commonly called OCT, allows clinicians to measure the retinal nerve fiber layer and ganglion cell complex with micrometer-level detail. These measurements help identify structural thinning that may not be obvious on examination alone.

When used for retinal imaging glaucoma evaluation, OCT is particularly helpful in early disease and in glaucoma suspects. A patient may have borderline eye pressure and an optic nerve that looks slightly suspicious. OCT can show whether the nerve fiber layer falls within expected limits or whether there is a pattern of thinning consistent with glaucoma.

Still, OCT is not perfect. It can produce false alarms in highly nearsighted eyes, tilted optic discs, eyes with certain retinal diseases, or scans with poor signal quality. Segmentation errors, where the software misidentifies retinal boundaries, can make a scan look abnormal when it is not. Good clinicians look at the raw scan quality, not just the color-coded summary.

The color map can be seductive. Green looks reassuring. Yellow and red look alarming. But those colors compare the patient to a reference database, and not every healthy eye fits neatly into that database. A stable yellow sector over many years may be less concerning than a green sector that steadily thins.

This is one reason baseline imaging is so useful. The first scan provides a reference point. Future scans show whether the structure remains stable or changes. In glaucoma, trend often matters more than a single snapshot.

Visual field testing: measuring function, not structure

If OCT shows the anatomy, visual field testing shows how the visual system performs. During the test, the patient looks into a bowl-shaped machine and presses a button when small lights appear in different areas of vision. The machine maps sensitivity across the visual field, especially peripheral vision, where glaucoma often starts.

Patients frequently dislike visual field testing. It is mentally tiring, and the lights can be faint by design. People worry they are “failing” the test if they miss some flashes. In reality, missing some lights is expected. The test is trying to find the threshold of perception.

The reliability indices matter. If a patient looks away often, presses the button too frequently, or becomes fatigued, the result may be hard to interpret. I have seen first-time visual fields look concerning, only to normalize once the patient understands the rhythm of the test. Conversely, a very reliable test with a repeatable arcuate defect matching OCT thinning deserves serious attention.

Visual field loss from glaucoma often follows recognizable patterns. It may create a nasal step, arcuate scotoma, or paracentral defect. Advanced glaucoma can constrict vision severely, sometimes leaving central vision intact until late. That is why people may have significant glaucoma and still read an eye chart well. Standard visual acuity, such as 20/20, does not rule out glaucoma.

Visual field testing and OCT complement each other. Structural damage may appear before field loss in some patients. In others, functional change is detected despite subtle structural findings. When both tests point in licensed optometrist the same direction, confidence rises.

Putting the pieces together: glaucoma suspect, ocular hypertension, or glaucoma

After an eye pressure test and additional evaluation, patients often fall into one of several categories. These labels are not meant to frighten or minimize risk. They guide follow-up and treatment.

A glaucoma suspect has one or more concerning features but not enough evidence for a definite diagnosis. The optic nerve may look suspicious, pressure may be borderline, or family history may be strong. Many glaucoma suspects never develop glaucoma, but they need periodic reassessment.

Ocular hypertension means the pressure is above the typical range, but there is no detectable optic nerve damage or visual field loss. The decision to treat depends on estimated risk. Some patients with ocular hypertension benefit from pressure-lowering drops or laser treatment. Others can be watched carefully.

Definite glaucoma means there is characteristic optic nerve damage, often supported by OCT and visual field findings. Pressure may be high, normal, or previously high but now controlled. Treatment focuses on lowering pressure enough to reduce the risk of further vision loss.

The distinction can shift over time. A patient monitored for ocular hypertension may remain stable for twenty years. Another may show progressive retinal nerve fiber layer thinning after two visits. Good glaucoma care allows the diagnosis and treatment plan to evolve as evidence accumulates.

Risk factors that change the meaning of your pressure result

Eye pressure is interpreted differently depending on the person attached to the number. A pressure of 22 mmHg may mean one thing in a healthy 32-year-old with thick corneas and no family history, and another in a 72-year-old with thin corneas and a sibling who went blind from glaucoma.

Key factors that influence glaucoma risk include:

1. Older age, particularly after 60, though glaucoma can occur earlier.
2. Family history of glaucoma in a first-degree relative.
3. African, Hispanic, or Asian ancestry, with risk patterns varying by glaucoma type.
4. Thin central corneal thickness or high myopia.
5. Prior eye injury, steroid exposure, certain eye surgeries, or conditions affecting eye drainage.

Steroid response deserves special mention. Some people develop significant pressure rises from steroid eye drops, injections, inhalers, nasal sprays, skin creams used near the eyes, or oral steroids. The risk varies by individual and potency of the medication. If someone has glaucoma or is a glaucoma suspect, steroid use should be discussed with both the prescribing doctor and eye care provider.

Angle anatomy also matters. Narrow angles can predispose some eyes to angle-closure glaucoma, where drainage becomes blocked by the iris. In these cases, pressure can rise suddenly or intermittently. A routine pressure check may be normal between episodes. Gonioscopy, a technique using a mirrored lens to examine the drainage angle, helps identify this risk.

When a pressure result needs urgent attention

Most elevated pressure readings are not emergencies. A patient with a pressure of 24 mmHg and no symptoms usually needs a careful workup, not panic. But some situations are different.

Acute angle-closure glaucoma can cause eye pain, redness, blurred vision, halos around lights, headache, nausea, and vomiting. The eye pressure may be very high, and the condition can threaten vision quickly. It is more common in eyes with narrow angles and may be triggered by pupil dilation in susceptible individuals, certain medications, or dim lighting, though often it occurs without an obvious cause.

Very high pressure after eye surgery, trauma, inflammation, or bleeding inside the eye also requires prompt assessment. The optic nerve can tolerate some pressure elevations briefly, but the risk rises when pressure is markedly elevated or sustained.

A practical rule is simple: high pressure with pain, redness, sudden blur, halos, nausea, or a recent procedure should be treated as urgent. A routine office reading that is mildly elevated in an otherwise comfortable eye is usually handled through scheduled evaluation and follow-up.

Target pressure: why your doctor may want a number lower than “normal”

Once glaucoma is diagnosed, clinicians often establish a target pressure. This is an estimated pressure range expected to slow or prevent further damage. It is not a magic line. It is a working goal that may change if the disease progresses or remains stable.

A patient with mild glaucoma might have a target in the mid to high teens. Someone with advanced glaucoma may need low teens or even single-digit pressures, depending on baseline pressure and rate of progression. The more damaged the optic nerve, the less reserve it has. A pressure that was safe years ago may not be safe once substantial nerve tissue has been lost.

Target pressure is usually based on several factors: untreated baseline pressure, severity of damage, life expectancy, rate of change, and risk of treatment side effects. A 45-year-old with early glaucoma faces decades of risk, so clinicians may treat more proactively. An 88-year-old with mild stable disease and other health issues may need a gentler approach.

This is where glaucoma monitoring becomes central. If OCT and visual fields remain stable over repeated visits, the target may be adequate. If progression continues, the target is lowered and treatment is adjusted.

Treatment options when pressure is too high for the optic nerve

The main proven strategy for glaucoma is lowering eye pressure. Treatment does not restore lost optic nerve tissue, but it can reduce the chance of further loss. The options include prescription drops, laser procedures, and surgery.

Eye drops are often first-line therapy. Prostaglandin analogs are commonly used because they lower pressure effectively with once-daily dosing for many patients. Other classes include beta blockers, alpha agonists, carbonic anhydrase inhibitors, and newer agents that affect outflow pathways. Each has possible side effects. Some cause redness, stinging, eyelash growth, darkening of the eyelid skin, dry mouth, fatigue, shortness of breath in susceptible patients, or allergy.

Selective laser trabeculoplasty, known as SLT, is used to improve drainage through the trabecular meshwork in open-angle glaucoma or ocular hypertension. It can reduce or delay the need for drops in many patients. The effect may last years, but it can wear off. SLT is not suitable for every glaucoma type, but it is now commonly discussed early in treatment rather than only after drops fail.

Surgery is considered when drops and laser are insufficient, poorly tolerated, or impractical. Minimally invasive glaucoma surgeries may be combined with cataract surgery in mild to moderate cases. Traditional filtering surgeries, such as trabeculectomy or tube shunt implantation, can achieve lower pressures but carry higher risks and require close postoperative care.

The “best” treatment depends on the eye, the patient’s health, cost, ability to use drops consistently, disease severity, and personal preference. A medication that looks ideal on paper is not ideal if the patient cannot afford it or cannot get it into the eye.

Why one missed drop can matter less than a missed pattern

Patients often feel guilty when they miss a glaucoma drop. Perfection is rare. What matters most is the pattern. Missing one dose occasionally is different from using drops only three days a week while believing the disease is controlled.

Drop technique also matters. Many people aim at the eye, blink rapidly, and wash much of the medication onto the cheek. A better method is to tilt the head back, pull the lower lid down slightly, place one drop in the pocket, close the eye gently, and avoid squeezing. If using more than one type of drop, spacing them by at least five minutes helps prevent the second from washing out the first.

Side effects should be reported, not silently endured. Red, irritated eyes may lead patients to stop treatment without telling anyone. There are usually alternatives. Preservative-free formulations, different drug classes, laser, or surgical options may solve a problem that otherwise undermines adherence.

What to ask after an eye pressure test

A good conversation after an eye pressure test should leave the patient with more than a number. It should clarify risk, next steps, and how the result fits previous findings.

Useful questions include:

1. What were my pressures in each eye, and how do they compare with prior visits?
2. Is my corneal thickness affecting how we interpret the reading?
3. Do my optic nerves look healthy, suspicious, or clearly glaucomatous?
4. Do I need OCT imaging, visual field testing, or gonioscopy?
5. How often should I return for glaucoma monitoring?

These questions are especially valuable when care is split between providers, such as an optometrist monitoring pressure and an ophthalmologist managing glaucoma. Keeping copies of pressure history, OCT reports, and visual field printouts can prevent duplication and help identify progression.

Common situations that create confusion

One common scenario is the patient who is told their pressure is “a little high” at an optical shop screening. Screening devices are useful, but they are not a diagnosis. The right next step is a comprehensive exam with repeat pressure measurement, optic nerve evaluation, and risk assessment. Many of these patients turn out to have low risk, but some are found early enough to prevent future loss.

Another scenario is pressure that rises after cataract surgery or another eye procedure. Short-term pressure spikes can occur, and most are managed successfully if recognized. Patients with known glaucoma may need closer pressure checks around surgery because their optic nerves have less tolerance for spikes.

A third situation involves patients with large optic nerve cups but normal pressure. Some have physiologic cupping, meaning their nerves are naturally shaped that way. Others have early glaucoma or normal-tension glaucoma. Baseline OCT, optic nerve photos, and visual fields help separate stable anatomy from disease.

High myopia creates its own challenges. Nearsighted eyes can have tilted discs, stretched retinal tissue, and OCT artifacts. Glaucoma diagnosis in these eyes often requires careful longitudinal observation. A single abnormal OCT sector may not prove glaucoma, but progressive change over time is harder to dismiss.

How often should pressure be checked?

Follow-up intervals depend on risk and disease severity. A low-risk glaucoma suspect may be examined every 6 to 12 months. Someone with ocular hypertension and multiple risk factors may need visits every 3 to 6 months at first. A patient with advanced or unstable glaucoma may require more frequent monitoring, especially after medication changes, laser, or surgery.

Pressure is usually checked at every glaucoma-related visit, but pressure alone is not enough. OCT may be repeated every 6 to 12 months in many glaucoma suspects or early glaucoma patients, though frequency varies. Visual field testing may be done once or twice a year, more often if progression is suspected or disease is advanced. In stable long-term cases, testing may be less frequent, but it should not disappear entirely.

The purpose of monitoring is not to collect data for its own sake. It is to detect whether the current plan is protecting the optic nerve. Glaucoma is usually slow, which is both a blessing and a challenge. Slow change can be missed unless measurements are repeated consistently and interpreted over time.

The emotional side of a borderline result

A borderline eye pressure result can leave patients in limbo. They do not have a clear diagnosis, but they cannot ignore the finding either. Some become anxious before every visit, worried that the number will jump. Others dismiss the issue because they see well.

Both reactions are understandable. Glaucoma is difficult because early disease usually has no symptoms. The patient may feel completely normal while the clinician discusses a lifelong condition. That disconnect can make follow-up seem optional.

I often frame borderline findings as an opportunity. If there is risk, finding it early gives everyone more room to act. A person monitored as a glaucoma suspect may never need treatment. If treatment becomes necessary, starting before meaningful vision loss is far better than discovering glaucoma after peripheral vision has already narrowed.

The goal is not to label every borderline pressure as disease. The goal is to avoid missing the eyes that are beginning to change.

What your result really means

An eye pressure test result means something, but it rarely means everything. A pressure of 14 can be reassuring in one patient and inadequate in another. A pressure of 24 can be a watch item or a treatment trigger. The difference lies in the optic nerve, corneal thickness, drainage angle, imaging, visual fields, and the pattern over time.

If your pressure is elevated, ask how confident the measurement is and what other tests are needed. If your pressure is normal but your optic nerve looks suspicious, do not assume pressure has cleared you. If you already have glaucoma, focus less on whether your number is inside the population “normal” range and more on whether it meets your individualized target.

Glaucoma care works best when it is steady and evidence-based. The eye pressure test opens the conversation. Retinal imaging, visual field testing, and careful glaucoma monitoring complete it. Together, they help answer the question that matters most: is the optic nerve staying stable, or is it at risk of losing ground?

Opticore Optometry Group, PC - BREA, CA

2500 E Imperial Hwy, Ste 196, Brea, CA 92821

Phone: (657) 445-2160

Website: opticoreyegroup.com/brea-ca.html